Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 76.68%-177.24K | 101.34%12.73K | 83.96%-74.74K | 50.61%-2.43M | -300.54%-255.3K | 72.67%-759.94K | 34.34%-951.91K | 43.35%-465.92K | -14.48%-4.93M | 107.88%127.31K |
| Net income from continuing operations | 66.21%-231.78K | 76.30%-325.41K | 74.05%-200.11K | 49.91%-2.73M | 110.52%104.75K | 58.96%-685.85K | 22.72%-1.37M | 22.74%-770.98K | -28.08%-5.44M | 39.33%-995.25K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---306.91K | --0 |
| Depreciation and amortization | --0 | --0 | --0 | 24.25%96.22K | 95.98%38.02K | 0.01%19.4K | 0.00%19.4K | 0.84%19.4K | 201.89%77.44K | -24.37%19.4K |
| Remuneration paid in stock | -85.83%7.98K | -78.68%12.68K | -60.40%22.59K | -45.67%209.97K | -55.54%37.14K | -50.52%56.31K | -55.91%59.49K | 5.17%57.04K | -33.94%386.5K | 10.33%83.53K |
| Other non cashItems | ---- | ---- | 100.05%1 | -107.82%-3.97K | 48.05%-7.34K | 102.66%2.46K | -98.21%2.74K | -145.45%-1.84K | 115.13%50.75K | 94.34%-14.12K |
| Change In working capital | 130.58%46.56K | -4.15%325.46K | -55.40%102.78K | -103.29%-10.12K | -141.39%-427.87K | 81.95%-152.26K | 1,664.36%339.55K | 135.36%230.46K | 193.21%307.42K | 494.77%1.03M |
| -Change in receivables | -57.74%66.59K | 515.13%258.62K | -65.25%92.72K | -93.33%42.66K | -125.76%-319.42K | 117.40%157.58K | -17.32%-62.3K | -25.44%266.8K | 2,101.83%639.4K | 19.64%1.24M |
| -Change in prepaid assets | -118.09%-1.88K | -50.10%3.87K | 96.22%-615 | -75.59%8.11K | 207.97%6.24K | 64.88%10.39K | -83.27%7.75K | -19.18%-16.28K | 190.63%33.21K | 81.71%-5.78K |
| -Change in payables and accrued expense | 94.33%-18.15K | -84.02%62.97K | 153.24%10.68K | 83.33%-60.89K | 42.78%-114.7K | -676.50%-320.23K | 1,415.87%394.1K | 91.85%-20.06K | -180.33%-365.2K | -73.98%-200.46K |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 76.68%-177.24K | 101.34%12.73K | 83.96%-74.74K | 50.61%-2.43M | -300.54%-255.3K | 72.67%-759.94K | 34.34%-951.91K | 43.35%-465.92K | -14.48%-4.93M | 107.88%127.31K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | |||||||||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 1,496.00%209.4K | 0 | -95.58%240.65K | -81.46%285.65K | -101.67%-15K | -100.50%-15K | 0.00%-15K | -2.97%5.45M | 30.34%1.54M |
| Net issuance payments of debt | --0 | --0 | --0 | 8.33%-55K | 33.33%-10K | 0.00%-15K | 0.00%-15K | 0.00%-15K | -140.00%-60K | 40.00%-15K |
| Net common stock issuance | --0 | ---- | ---- | -94.55%300K | -82.22%300K | --0 | ---- | ---- | 62.96%5.51M | 38.47%1.69M |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -87.42%297.47K | --0 |
| Net other financing activities | --0 | ---- | ---- | 98.54%-4.35K | ---- | ---- | ---- | ---- | -182.35%-298.15K | -1,033.75%-131.92K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 1,496.00%209.4K | --0 | -95.58%240.65K | -81.46%285.65K | -101.67%-15K | -100.50%-15K | 0.00%-15K | -2.97%5.45M | 30.34%1.54M |
| Net cash flow | ||||||||||
| Beginning cash position | -61.71%370.62K | -92.32%148.49K | -90.76%223.23K | 27.50%2.42M | -74.20%192.89K | -63.23%967.83K | 83.02%1.93M | 27.50%2.42M | 183.29%1.89M | -69.00%747.67K |
| Current changes in cash | 77.13%-177.24K | 122.97%222.13K | 84.46%-74.74K | -520.75%-2.19M | -98.18%30.34K | 58.88%-774.94K | -161.38%-966.91K | 42.58%-480.92K | -57.49%521.07K | 422.26%1.67M |
| End cash Position | 0.26%193.39K | -61.71%370.62K | -92.32%148.49K | -90.76%223.23K | -90.76%223.23K | -74.20%192.89K | -63.23%967.83K | 83.02%1.93M | 27.50%2.42M | 27.50%2.42M |
| Free cash from | 76.68%-177.24K | 101.34%12.73K | 83.96%-74.74K | 50.61%-2.43M | -300.54%-255.3K | 72.67%-759.94K | 34.34%-951.91K | 43.35%-465.92K | -12.26%-4.93M | 107.49%127.31K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.